enterobacterales - Robuta Search

https://pmc.ncbi.nlm.nih.gov/articles/PMC9453065/ Hospital outbreak of carbapenem-resistant Enterobacterales associated with a bla OXA-48 plasmid... A hospital outbreak of carbapenem-resistant Enterobacterales was detected by routine surveillance. Whole genome sequencing and subsequent analysis revealed a... https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2024.1471477/full Frontiers | Clinical and genomic characterization of carbapenem-resistant Enterobacterales... BackgroundCarbapenem-resistant Enterobacterales (CRE) bloodstream infections (BSIs) pose a significant risk to patients with hematologic malignancies, yet th... frontiers clinical genomic characterization carbapenem https://pmc.ncbi.nlm.nih.gov/articles/PMC8435449/ Identification and infection control of carbapenem-resistant Enterobacterales in intensive care... Infections with multidrug-resistant organisms among patients in intensive care units (ICUs) are associated with high mortality. Among multidrug-resistant... infection control identification https://www.santepubliquefrance.fr/resistance-aux-antibiotiques/article/acquisition-enterobacterales-carrying-colistin-resistance-gene-mcr-following-travel-tropics Acquisition of Enterobacterales carrying the colistin resistance gene mcr following travel to the... https://pmc.ncbi.nlm.nih.gov/articles/PMC10930850/ Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and... The prevalence of carbapenem-resistant Enterobacterales (CRE) presents a significant challenge in clinical anti-infective treatment. This study aims to... molecular epidemiology clinical isolation carbapenem resistant https://www.cdc.gov/cre/about/?CDC_AAref_Val=https://www.cdc.gov/hai/organisms/cre/ About Carbapenem-resistant Enterobacterales (CRE) | CRE | CDC CRE are germs resistant to one or several antibiotics called carbapenem resistant enterobacterales cre cdc https://www.fda.gov/drugs/development-resources/fda-rationale-polymyxin-breakpoints-enterobacterales-pseudomonas-aeruginosa-and-acinetobacter-spp FDA Rationale for Polymyxin Breakpoints for Enterobacterales, Pseudomonas aeruginosa, and... Rationale for Polymyxin Breakpoints for Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp. pseudomonas aeruginosa fda rationale polymyxin breakpoints https://pmc.ncbi.nlm.nih.gov/articles/PMC12421896/ Performance evaluation of plazomicin susceptibility testing of Enterobacterales on VITEK 2 and... The objective of the present study was to evaluate the VITEK 2 antimicrobial susceptibility test (AST) for Gram-negative (GN) plazomicin performance using the... performance evaluation susceptibility testing vitek 2 plazomicin